ATA. Tipold

A. Tipold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. Tipold has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Iwan Anton Burgener

    Clinical Unit of Small Animals Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria

    2 shared publications
  • A Zurbriggen

    1 shared publication
  • A. Zurbriggen

    Institute of Animal Neurology, University of Berne, Länggass-Strasse 122, CH-3012 Berne, Switzerland, Tel.: +41-31-6312664, Fax: +41-31-6312534

    1 shared publication
  • G. Barben

    Institute of Animal Neurology, University of Berne, Länggass-Strasse 122, CH-3012 Berne, Switzerland, Tel.: +41-31-6312664, Fax: +41-31-6312534

    1 shared publication
  • M. Vandevelde

    Institute of Animal Neurology, University of Berne, Länggass-Strasse 122, CH-3012 Berne, Switzerland, Tel.: +41-31-6312664, Fax: +41-31-6312534

    1 shared publication
  • P. Moore

    VM Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, USA

    1 shared publication

Latest Publications

  • Early T cell response in the central nervous system in canine distemper virus infection

    by A. Tipold, P. Moore, A. Zurbriggen, I. Burgener, G. Barben, M. Vandevelde

    The initial demyelinating lesions in canine distemper virus (CDV) infection develop during a period of severe immunosuppression in the absence of inflammation. In vitro and in vivo studies suggest that early demyelination is due to directly virus-induced oligodendroglial changes. In the present spatiotemporal study in experimentally CDV-infected dogs we observed diffuse up-regulation of T cells throughout the central nervous system (CNS) and T cell invasion in early demyelinating lesions. Invasion of T cells in the CNS occurred despite severe immunosuppression and without any perivascular cuffing. However, the major fraction of invading T cells correlated with sites of viral replication and coincided with the demonstration of an early immune response against the nucleocapsid protein of CDV. Activation of microglial cells was thought to have elicited the migration of T cells to the CNS by secretion of chemokines: marked IL-8 activity was found in the CSF of dogs with acute lesions. In areas of early demyelination, large numbers of CD3+ cells accumulated in the tissue in the absence of any morphological sign of inflammation. Whether the T cells at lesion sites contribute to the development of acute demyelination remains uncertain at this stage. Antiviral cytotoxicity was not apparent since viral clearance in demyelinating lesions is only effective when B cells and concurring antiviral antibody production appeared in the subacute and chronic inflammatory stage of the disease. CD3+ cells appear to persist for several weeks after infection since they were also found in recovered dogs that did not develop demyelination. Accumulation of immune cells, including a significant proportion of resting T cells (CD45RA+) in the CNS in the early stages of the disease may facilitate the later development of the intrathecal immune response and associated immunopathological complications.